文献速递血管炎

秋水仙碱通过靶向DTL介导的ABCA1泛素化降解增强巨噬细胞胆固醇外流

Colchicine enhances macrophage cholesterol efflux by targeting DTL-mediated ubiquitination and degradation of ABCA1.
PubMed 文献 · RMD Open · 2026-07-08

本研究在多种细胞模型中探讨秋水仙碱对动脉粥样硬化心血管疾病临床获益的潜在药理机制,聚焦胆固醇外流。结果显示秋水仙碱通过抑制DTL表达、破坏DTL与ABCA1相互作用,增加ABCA1蛋白稳定性,促进ABCA1介导的胆固醇外流并减少泡沫细胞形成。

要点

  • 秋水仙碱通过抑制DTL表达减少ABCA1泛素化降解,增强胆固醇外流。
  • 秋水仙碱促进胆固醇外流并逆转巨噬细胞泡沫细胞形成。
  • 提示秋水仙碱或可拓展用于心血管二级预防。

核心结论

  • 秋水仙碱通过抑制DTL表达并破坏其与ABCA1的相互作用,增加ABCA1蛋白稳定性,增强ABCA1介导的胆固醇外流,减少泡沫细胞形成。

研究设计与样本

  • 研究在多种细胞模型中进行,先用Cell Counting Kit-8 assay评估细胞活力并筛选秋水仙碱最佳剂量。
  • 采用Oil Red O染色、商业试剂盒检测和BODIPY-胆固醇标记分析巨噬细胞内脂质积累、泡沫细胞形成和胆固醇外流率。
  • 通过分子对接和转录组测序探索潜在靶点与机制,并用定量逆转录PCR、ABCA1降解分析、质粒构建与转染、免疫共沉淀和免疫印迹等细胞实验验证。

主要发现

  • 秋水仙碱显著促进胆固醇外流,逆转巨噬细胞泡沫细胞形成。
  • 研究首次发现DTL作为关键E3泛素连接酶参与ABCA1泛素化调控。
  • 秋水仙碱抑制DTL表达并破坏DTL与ABCA1相互作用,增加ABCA1蛋白稳定性。

临床怎么用

  • 秋水仙碱显示作为新治疗药物重定位的潜力,其逆转泡沫细胞形成的能力提示临床用途可从痛风管理扩展至心血管二级预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to elucidate the potential pharmacological mechanisms by which colchicine confers clinical benefits in patients with atherosclerotic cardiovascular disease, focusing on its effects on cholesterol efflux. METHODS: This study was conducted in multiple cellular models. First, cell viability was assessed and the optimal dosage of colchicine was screened via the Cell Counting Kit-8 assay. Subsequently, Oil Red O staining, commercial kit detection and Boron dipyrromethene (BODIPY) -cholesterol labelling were employed to analyse intracellular lipid accumulation, foam cell formation and cholesterol efflux rate in macrophages, respectively. Furthermore, molecular docking and transcriptome sequencing were performed to explore the potential therapeutic targets and underlying mechanisms of colchicine, followed by a series of cellular experiments (quantitative reverse transcription-PCR, ATP-binding cassette transporter A1 (ABCA1) degradation analysis, plasmid construction and transfection, co-immunoprecipitation, immunoblotting) for comprehensive validation of the identified potential mechanisms. RESULTS: In the present study, we demonstrate that colchicine markedly promotes cholesterol efflux, a key process that reverses macrophage foam cell formation and consequently contributes to its cardioprotective effects. We identified modulation of the ubiquitination of ABCA1 as the pivotal mechanism by which colchicine enhances cholesterol efflux. Our findings reveal for the first time that denticleless E3 ubiquitin protein ligase homologue (DTL) functions as a crucial E3 ligase in this regulatory pathway. Mechanistically, colchicine suppresses DTL expression and disrupts its interaction with ABCA1, leading to increased ABCA1 protein stability, enhanced ABCA1-mediated cholesterol efflux and a subsequent reduction in foam cell formation. CONCLUSION: Colchicine shows great promise for drug repurposing as a novel therapeutic agent. Its strong capacity to reverse foam cell formation highlights its potential to extend clinical use beyond gout management to cardiovascular secondary prevention.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Tong L, Wu W, Wang Y, et al. Colchicine enhances macrophage cholesterol efflux by targeting DTL-mediated ubiquitination and degradation of ABCA1. RMD Open. 2026. PMID: 42419788. doi:10.1136/rmdopen-2025-006553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。